GLP-1a: Going beyond Traditional Use

Autor: Lucas Fornari Laurindo, Sandra Maria Barbalho, Elen Landgraf Guiguer, Maricelma da Silva Soares de Souza, Gabriela Achete de Souza, Thiago Marques Fidalgo, Adriano Cressoni Araújo, Heron F. de Souza Gonzaga, Daniel de Bortoli Teixeira, Thais de Oliveira Silva Ullmann, Katia Portero Sloan, Lance Alan Sloan

Publikováno v: International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 23, Iss 739, p 739 (2022)

Glucagon-like peptide-1 (GLP-1) is a human incretin hormone derived from the proglucagon molecule. GLP-1 receptor agonists are frequently used to treat type 2 diabetes mellitus and obesity. However, the hormone affects the liver, pancreas, brain, fat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5a54e6f426b602a3eb0c6dfa6ab91dd
https://pubmed.ncbi.nlm.nih.gov/35054924